ArticleClinical and translational science2024

Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK).

Majdoleen Alalawneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.